| Literature DB >> 30548554 |
Jennifer M Racz1, Matthew S Block2, Christian L Baum3, James W Jakub1.
Abstract
Some melanomas develop a striking avidity for lymphatic spread. In spite of multiple recurrences, patients can remain years without visceral metastasis. There is clearly a biologic reason for this lymphotrophic pattern of growth and dissemination, which we have yet to uncover. In-transit metastases have widely diverse clinical presentations and can be a stubborn disease to cure. As a result, a host of treatments exist that should be tailored to the individual patient.Entities:
Keywords: diphenylcyclopropenone; in transit; intralesional therapy; limb perfusion; melanoma, stage III; talimogene laherparepvec
Mesh:
Year: 2018 PMID: 30548554 DOI: 10.1002/jso.25330
Source DB: PubMed Journal: J Surg Oncol ISSN: 0022-4790 Impact factor: 3.454